Adam Pardes is an evidence-based entrepreneur, public speaker, and scientific researcher with extensive experience in academic settings and leading SaaS-based product growth. Prior to NeuroFlow, Adam entered the bioengineering doctoral program at the University of Pennsylvania and published nearly a dozen peer-reviewed manuscripts, while also consulting for high-growth startups. Since transitioning from academia to industry, Adam has maintained a research-focused approach to leveraging digital technologies to enhance the access, delivery, and effectiveness of mental healthcare, particularly for vulnerable populations including Veterans, children, and Medicare/Medicaid members. Adam is the Principal Investigator for a $225K Phase I STTR grant from the National Science Foundation that was recently awarded to NeuroFlow in collaboration with the Philadelphia Veteran Affairs Hospital.
